Literature DB >> 6787713

Cost-effectiveness of duodenal ulcer treatment.

A J Culyer, A K Maynard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787713     DOI: 10.1016/0160-7995(81)90003-4

Source DB:  PubMed          Journal:  Soc Sci Med Med Econ        ISSN: 0160-7995


× No keyword cloud information.
  7 in total

1.  The reliability of cost-utility estimates in cost-per-QALY league tables .

Authors:  S Petrou; M Malek; P G Davey
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Cost-effective prescribing in elderly people.

Authors:  D J Morgan; C A Sutters; B Livesley
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  The Japanese Society of Gastroenterology. Proceedings of the 71st general meeting. Sapporo, Japan, May 22-24, 1985.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1986-04

Review 4.  Formulary management of antiulcer drugs: economic considerations.

Authors:  P P Tucker; D B Nash
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

5.  Cost-effectiveness analysis.

Authors:  R Robinson
Journal:  BMJ       Date:  1993-09-25

6.  Essentials of health economics. Part V--Assessing the costs and benefits of treatment alternatives.

Authors:  M F Drummond; G H Mooney
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

Review 7.  Formulary management of proton pump inhibitors.

Authors:  M F Byrne; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.